Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-Human IgG Antibody (R1C56)

Catalog #:   RHJ92831 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IHC, WB
Accession: P01857, P01859, P01860, P01861
Overview

Catalog No.

RHJ92831

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IHC: 1:100-1:200, WB: 1:1000-1:2000

Target

HDC, Heavy chain disease protein, Human immunglobulin G, Ig gamma 1 chain C region, Ig gamma 2 chain C region, Ig gamma 3 chain C region, Ig gamma 4 chain C region, IgG heavy chain locus, IGHG1, IGHG2, IGHG3, IGHG4, Human IgG

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P01857, P01859, P01860, P01861

Applications

IHC, WB

Form

Liquid

Storage buffer

PBS with 0.05% sodium azide,0.05% BSA and 50% glycerol.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4 ℃ short term (1-2 weeks). Store at -20 ℃ 12 months. Store at -80 ℃ long term.

Clone ID

R1C56

Data Image
  • Immunohistochemical
    Immunohistochemical analysis of paraffin-embedded human spleen, using Human IgG Antibody.
  • Immunohistochemical
    Immunohistochemical analysis of paraffin-embedded Human colon, using the Antibody at 1:100 dilution.
  • Immunohistochemical
    Immunohistochemical analysis of paraffin-embedded Mouse skin, using the Antibody at 1:100 dilution.
  • Western blot
    Western blot analysis of Human IgG expression in Human plasma lysate.
References

Myomedin variants developed for in vitro PD-L1 diagnostics in tissue samples of non-small cell lung carcinoma patients., PMID:40514707

Autoantibody clusters in rheumatoid arthritis are not driven by antigen specificity or isotype., PMID:40514057

Patrolling monocytes mediate virus neutralizing IgG effector functions: beyond neutralization capacity., PMID:40510351

IgG4-Related Disease: Current and Future Insights into Pathological Diagnosis., PMID:40508133

Leveraging the Polymorphism of the Merozoite Surface Protein 2 (MSP2) to Engineer Molecular Tools for Predicting Malaria Episodes in a Community., PMID:40508084

Anti-Tumor Activities of Anti-Siglec-15 Chimeric Heavy-Chain Antibodies., PMID:40507880

Rapid detection of SARS-CoV-2 antigen based on IgG colloidal gold immunochromatographic strip., PMID:40506633

Identification of a direct interaction between the Fab domains of IgG antibodies and human FcRn upon IgG-FcRn complex formation., PMID:40506471

circLRCH3-FUS interaction stabilizes IFI35 mRNA, inhibiting autophagy and aggravating podocyte pyroptosis in lupus nephritis., PMID:40505228

Clinical Features of Children With MOG-IgG Who Fulfill Criteria of Multiple Sclerosis and Overlapping Disorders., PMID:40505071

The development of functional opsonophagocytic assays to evaluate antibody responses to Klebsiella pneumoniae capsular antigens., PMID:40503906

An Unusual Presentation of Bullous Skin Lesions During Pregnancy., PMID:40503690

Plasmapheresis for refractory toxic epidermal necrolysis unresponsive to conventional therapy: a case report and literature review., PMID:40503234

Monoclonal Antibodies to Thyrotropin Receptor With Thyroid-Stimulating Activity Activate the NF-κB Pathway to Induce Chemokine Expression., PMID:40500868

Oligodendroglia in Neuromyelitis Optica Spectrum Disorder., PMID:40500507

Topical delivery of a human single-domain antibody targeting IL-33 to inhibit mucosal inflammation., PMID:40500403

Development and Validation of Novel Cell-free Direct Neutralization Assay for SARS-CoV-2., PMID:40499786

Cytotoxic IgG: Mechanisms, functions, and applications., PMID:40499518

Germline-encoded recognition of peanut underlies development of convergent antibodies in humans., PMID:40498852

Immune response induced by the recombinant novel coronavirus vaccine (Adenovirus type 5 vector) (Ad5-nCoV) in persons living with HIV (PLWH)., PMID:40498774

Longitudinal SARS-CoV-2 antibody response in a healthcare worker cohort utilising the Abbott Alinity® anti-nucleocapsid assay., PMID:40498754

Detectable SARS-CoV-2 specific immune responses in recovered unvaccinated individuals 250 days post wild type infection., PMID:40498720

Seroprevalence of Toxoplasmosis and the Possible Role of C-Reactive Protein in the Pathogenesis of Myocardial Infarction in Patients from Iraq; A Case Control Study., PMID:40498362

Profiling of Anti-glycan IgA and IgG in Oral Fluid Using a Glycan Microarray., PMID:40498306

A Rare Case of Warm Autoimmune Hemolytic Anemia With Intravascular Hemolysis: A Case Report., PMID:40497195

Efficacy of Subcutaneous Immunoglobulin in the Postoperative Management After Pediatric Living Donor Liver Transplantation., PMID:40495281

Immunoglobulin G4-related ophthalmic disease with orbital deep hemangioma: A case report., PMID:40494658

Severity of Primary and Secondary Dengue Virus 1 Infections: A Hospital-Based Study in Puerto Rico, 2012-2014., PMID:40494336

Rare case of tacrolimus-induced immune hemolytic anemia in a child after liver transplantation., PMID:40493980

Rituximab as First-Line Compared to Escalation Immunotherapy Is Associated With Lower Disability Accumulation in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Multicenter Cohort Study From Germany and the United Kingdom., PMID:40492480

Design of experiments for the optimization of sample preparation for bottom-up targeted protein LC-MS/MS workflows., PMID:40492479

Demographic characteristics and disease severity associated with IgA/IgG deposition patterns in autoimmune bullous diseases: a cohort study based on a registry database., PMID:40491920

Dual BLyS/APRIL targeted therapy with telitacicept in rituximab-refractory SLE-associated neuromyelitis optica spectrum disorder: a case report., PMID:40491913

Correlation study between clinical phenotypes and autoantibodies in systemic sclerosis in Southwest China., PMID:40489831

Treatment Patterns and Disease Burden of Juvenile Myasthenia Gravis in the United States: A Cohort Study Using Health Care Claims Databases., PMID:40489715

Elevated eosinophil-to-lymphocyte ratio (ELR) as a predictor of relapse for IgG4-related disease: a retrospective study across a decade., PMID:40488799

Serosurveillance of Crimean-Congo hemorrhagic fever virus antibodies in livestock as a reservoir for human infection in Afghanistan., PMID:40486752

A Rare Fatal Case of Hemophagocytic Lymphohistiocytosis With Central Pontine Myelinolysis in the Setting of Epstein-Barr Virus Reactivation., PMID:40486437

Interpretable web-based machine learning model for predicting intravenous immunoglobulin resistance in Kawasaki disease., PMID:40484951

Prevalence, knowledge, attitudes, and practices regarding Chagas disease in Guanare, Venezuela: a cross-sectional study., PMID:40484948

Clinical and immunopathological assessment of the oral mucosa in coeliac disease: a pilot study., PMID:40483462

Development of antibodies against severe fever with thrombocytopenia syndrome virus nucleoprotein for diagnosis., PMID:40481890

Serological analysis of gluten-related antibodies in idiopathic neuropathies and cerebellar ataxia., PMID:40481865

Immune age is correlated with decreased TCR clonal diversity and antibody response to SARS-CoV-2., PMID:40481111

Defining Aedes aegypti density thresholds for preventing human arboviral infections., PMID:40480602

Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19)., PMID:40479932

Development and Concordance of Binding and Neutralizing Assays to Determine SARS-CoV-2 Antibody Activity in Human Milk., PMID:40475854

Avidity of pertussis toxin antibodies following vaccination with genetically versus chemically detoxified pertussis toxin-containing vaccines during pregnancy., PMID:40475765

Steroid refractory immune-related acute disseminated encephalomyelitis (ADEM) successfully treated with 2nd and 3rd line immunosuppressive therapy., PMID:40473324

Pathogen-specific exposure is associated with multisite chronic pain: A prospective cohort study., PMID:40473045

Datasheet
$ 350
Product specifications
100 μg 350 1 mg 1750 50 μg 220

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human IgG Antibody (R1C56) [RHJ92831]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only